Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Myra L. Chang"'
Predicting and Defining Steroid Resistance in Pediatric Nephrotic Syndrome Using Plasma Metabolomics
Autor:
Jessica R. Gooding, Shipra Agrawal, Susan McRitchie, Zach Acuff, Michael L. Merchant, Jon B. Klein, William E. Smoyer, Susan J. Sumner, John Mahan, Hiren Patel, Richard F. Ransom, Cynthia Pan, Denis F. Geary, Myra L. Chang, Keisha L. Gibson, Franca M. Iorember, Patrick D. Brophy, Tarak Srivastava, Larry A. Greenbaum
Publikováno v:
Kidney International Reports, Vol 5, Iss 1, Pp 81-93 (2020)
Introduction: Nephrotic syndrome (NS) is a kidney disease that affects both children and adults. Glucocorticoids have been the primary therapy for >60 years but are ineffective in approximately 20% of children and approximately 50% of adult patients.
Externí odkaz:
https://doaj.org/article/1b5280e5d877451bafee09b406b2ee8f
Autor:
Shipra Agrawal, Michael L. Merchant, Jiro Kino, Ming Li, Daniel W. Wilkey, Adam E. Gaweda, Michael E. Brier, Melinda A. Chanley, Jessica R. Gooding, Susan J. Sumner, Jon B. Klein, William E. Smoyer, John Mahan, Hiren Patel, Richard F. Ransom, Cynthia Pan, Denis F. Geary, Myra L. Chang, Keisha L. Gibson, Franca M. Iorember, Patrick D. Brophy, Tarak Srivastava, Larry A. Greenbaum
Publikováno v:
Kidney International Reports, Vol 5, Iss 1, Pp 66-80 (2020)
Introduction: Nephrotic syndrome (NS) is a characterized by massive proteinuria, edema, hypoalbuminemia, and dyslipidemia. Glucocorticoids (GCs), the primary therapy for >60 years, are ineffective in approximately 50% of adults and approximately 20%
Externí odkaz:
https://doaj.org/article/4a6071bc69c54f03bf4f8c130ca5d000
Autor:
Sagar Bhayana, Yue Zhao, Michael Merchant, Timothy Cummins, Julie A. Dougherty, Yu Kamigaki, Wimal Pathmasiri, Susan McRitchie, Laura H. Mariani, Susan Sumner, Jon B. Klein, Lang Li, William E. Smoyer, John Mahan, Hiren Patel, Richard F. Ransom, Cynthia Pan, Denis F. Geary, Myra L. Chang, Keisha L. Gibson, Franca M. Iorember, Patrick D. Brophy, Tarak Srivastava, Larry A. Greenbaum
Publikováno v:
Kidney International Reports.
Autor:
Shipra Agrawal, Michael E. Brier, Bryce A. Kerlin, William E. Smoyer, John Mahan, Hiren Patel, Richard F. Ransom, Cynthia Pan, Denis F. Geary, Myra L. Chang, Keisha L. Gibson, Franca M. Iorember, Patrick D. Brophy, Tarak Srivastava, Larry A. Greenbaum
Publikováno v:
Kidney International Reports
Introduction Glucocorticoids (GCs) are the primary treatment for nephrotic syndrome (NS), although ∼10% to 20% of children develop steroid-resistant NS (SRNS). Unfortunately, there are no validated biomarkers able to predict SRNS at initial disease
Autor:
Shipra Agrawal, William E. Smoyer, Adam E. Gaweda, Richard F. Ransom, John D. Mahan, Larry A. Greenbaum, Michael E. Brier, Cynthia G. Pan, Denis F. Geary, Michael L. Merchant, Hiren P. Patel, Jiro Kino, Jessica Gooding, Daniel W. Wilkey, Keisha L. Gibson, Jon B. Klein, Susan Sumner, Myra L. Chang, Melinda A. Chanley, Franca M. Iorember, Patrick D. Brophy, Tarak Srivastava, Ming Li
Publikováno v:
Kidney International Reports
Kidney International Reports, Vol 5, Iss 1, Pp 66-80 (2020)
Kidney International Reports, Vol 5, Iss 1, Pp 66-80 (2020)
Introduction: Nephrotic syndrome (NS) is a characterized by massive proteinuria, edema, hypoalbuminemia, and dyslipidemia. Glucocorticoids (GCs), the primary therapy for >60 years, are ineffective in approximately 50% of adults and approximately 20%